The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.

Guests

  • Dr. Paul Antony chief medical officer for the Pharmaceutical Research and Manufacturers of America
  • Dr. Janet Woodcock deputy commissioner and chief medical officer of the FDA
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

The Future Of The United Nations

Thursday, Mar 26 2015The United Nations has recently come under attack for its handling of both the Ebola outbreak and the war in Syria. It has prompted some to question what the role of the U.N. should be on the international stage. We look at the relevance of the U.N., 70 years after its creation.

The Future Of U.S. Military Presence in Afghanistan

Wednesday, Mar 25 2015Nearly 10,000 U.S. military personnel remain in Afghanistan after combat forces withdrew last year. We explore a meeting between U.S. and Afghan officials this week, prospects for Congressional approval of additional troops and the future of security in the region.